Balance Sheet View
What does Bunge Global SA’s latest financial snapshot show?
Mixed. The strongest factor is scale after Viterra, but the main concern is leverage and weak conversion from sales growth into per-share earnings.
Bunge Global SA’s latest verified snapshot covers FY2025 and the 2026-03-31 quarter. The verdict combines growth, profitability, cash generation, balance-sheet capacity, and capital efficiency, and it also fits a broader read on Exploring Bunge Limited (BG) Investor Profile: Who's Buying and Why?
Deeper analysis should start with free cash flow, because weak cash conversion can strain debt service even when operating income is rising from $111B and operating income growth is 7406% for 2026-03-31.
Revenue Quality
Is Bunge Global SA’s revenue growth turning into quality earnings?
Mixed. Bunge Global SA’s FY2025 revenue jump was strong, but earnings quality looks less clean because adjusted EPS and GAAP diluted EPS fell versus 2024, pointing to growth that was helped by acquisition scale and volumes rather than fully improved per-share profit.
Bunge Global SA showed more growth quantity than growth quality in FY2025. Investors compare revenue durability with operating income, net income, and EPS across the same annual periods to see whether sales growth actually converts into higher profits for the business and for shareholders.
| Measure | Latest Period | Previous Period | Quality Test | Investor Meaning |
|---|---|---|---|---|
| Revenue | $7033B, 755% in FY2025 | FY2024 revenue not supplied in the prompt | Acquisition-led and volume-led | The Viterra deal and higher grain volumes support scale, but this is less repeatable than purely organic growth. |
| Operating Income | FY2025 operating income not supplied in the prompt | FY2024 operating income not supplied in the prompt | Unclear | Without this line, investors cannot confirm whether the revenue increase improved operating leverage. |
| Net Income | FY2025 net income not supplied in the prompt | FY2024 net income not supplied in the prompt | Integration costs, pricing, mix, and other agribusiness effects may have reduced conversion | Final earnings matter because they show how much of the revenue increase reached the bottom line. |
| Diluted EPS | $493 in FY2025 | $799 in 2024 | Per-share results weakened despite bigger sales | Shareholders did not get the same earnings growth that revenue growth suggested. |
How durable is Bunge Global SA’s revenue growth?
The strongest durability signal is larger soybean processing volume of 4101M metric tons and grain merchandising volume of 6717M metric tons in FY2025. The biggest limitation is commodity exposure, where buyer-supplier pressure, pricing, mix, and integration costs can change quickly.
- Demand Quality: FY2025 volumes suggest recurring trade and processing demand, but agribusiness demand remains cyclical and tied to commodity flows.
- Pricing and Volume: The prompt shows volume support and acquisition-led revenue growth; the exact split between price, volume, and mix is not supplied.
- Diversification: Revenue is still exposed to commodity-linked processing and merchandising, so concentration risk remains meaningful across products and margins.
That makes profitability and cash conversion the next test, and Exploring Bunge Limited (BG) Investor Profile: Who's Buying and Why? helps frame who may be backing that view.
Cash Conversion
Are Bunge Limited’s profits converting into cash?
Not cleanly in the latest data. Q1 2026 showed strong reported profit metrics, but operating cash flow growth of -14046% and free cash flow growth of -20976% point to much weaker cash conversion than earnings alone suggest.
Bunge Limited reported Q1 2026 revenue of $2186B, gross profit of $164B, operating income of $111B, EBITDA of $135B, and net income of $6800M. Profit analysis should stay separate from cash analysis here: interest expense of $16600M, total other income expenses net of -$105B, working capital intensity, inventories, capex, and non-cash items all shape how much earnings turn into cash. For mission and strategic context, see Mission Statement, Vision, & Core Values (2026) of Bunge Limited (BG).
| Measure | Latest Period | Previous Period | Verified Driver | Investor Meaning |
|---|---|---|---|---|
| Gross Margin | Unavailable from supplied data for Q1 2026. | Unavailable from supplied data. | Gross profit and revenue are supplied, but no verified margin was provided. | Product economics cannot be confirmed from the supplied margin data alone. |
| Operating Margin | Unavailable from supplied data for Q1 2026. | Unavailable from supplied data. | Operating income is supplied, but no verified margin was provided. | Scale and operating efficiency cannot be judged precisely without the margin. |
| Net Margin | Unavailable from supplied data for Q1 2026. | Unavailable from supplied data. | Net income is supplied, but no verified margin was provided. | Final profitability is visible, but not as a verified margin trend. |
| Operating Cash Flow | 2026-03-31, growth of -14046% | Unavailable from supplied data. | Weak conversion likely reflects working capital and non-cash effects, but the bridge was not supplied. | Reported earnings are not translating into cash at the same rate. |
| Free Cash Flow | 2026-03-31, growth of -20976% | Unavailable from supplied data. | Growth capital expenditure of 3755% and projected annual capital expenditures of $15B–$17B for 2025–2026. | Capex pressure leaves less cash for reinvestment, debt reduction, or shareholder returns. |
What most affects Bunge Limited’s cash conversion?
The strongest verified pressure is capital intensity, with growth capex of 3755% and projected annual capital expenditures of $15B–$17B for 2025–2026, alongside likely working capital swings that were not fully bridged in the supplied data.
- Main Driver: Capex and working capital look structural for now, because a large agricultural processing business needs inventory and fixed investment.
- Evidence Gap: The supplied data does not show the full cash-flow bridge for inventories, receivables, payables, or non-cash charges.
- Metric to Monitor: Watch operating cash flow, free cash flow, and capex versus EBITDA.
Liquidity Profile
Can Bunge Global SA handle debt and liquidity needs after the Viterra deal?
Mixed. Bunge Global SA has strong near-term liquidity, but the main concern is leverage clarity and refinancing risk because debt definitions differ across reporting sources, so analysts should reconcile debt before modeling net debt.
Cash alone does not tell the full story. For Bunge Global SA, the real test is whether current assets, inventory quality, debt service, solvency, and refinancing access line up with its near-term obligations and investment needs. That matters even more after Viterra, when balance-sheet structure and asset mix can change quickly.
| Area | Latest Evidence | Assessment | Investor Meaning |
|---|---|---|---|
| Cash and Working Capital | Cash And Cash Equivalents of $83900M, Short Term Investments of $86200M, Cash And Short Term Investments of $170B, Total Current Assets of $2709B, Total Current Liabilities of $1694B, Inventory of $1543B. | Strong | Near-term obligations look covered, and inventory plus liquid assets give Bunge Global SA room to fund operations. |
| Total and Net Debt | Total debt of $146B as of March 31, 2026; FMP Enterprise Values also lists Add Total Debt: $1629B; Short Term Debt of $471B; Long Term Debt of $995B. | Mixed | Leverage appears manageable only if debt definitions are reconciled before net debt is modeled. |
| Debt Service and Refinancing | Total Current Liabilities of $1694B against Cash And Short Term Investments of $170B, with no supplied interest expense or maturity schedule. | Mixed | Bunge Global SA likely has flexibility, but refinancing analysis should stay conservative until debt terms are clearer. |
| Asset Quality | Total Assets of $4758B, Readily marketable inventories of $134B, Inventory of $1543B. | Mixed | Inventory supports liquidity, but commodity-price swings can affect realizable value and working-capital needs. |
| Liabilities and Equity | Total Liabilities of $3010B and Total Stockholders Equity of $1605B. | Strong | The equity base is sizable relative to liabilities, which helps absorb shocks and supports funding capacity. |
Which balance-sheet risk matters most for Bunge Global SA?
Debt definition and refinancing risk matter most. The reported total debt of $146B conflicts with Add Total Debt: $1629B, so investors should first verify which measure matches operating debt.
- Current Exposure: Cash And Short Term Investments of $170B versus Total Current Liabilities of $1694B.
- Protection: Total Current Assets of $2709B and Total Stockholders Equity of $1605B provide a large buffer.
- Warning Signal: Watch whether reported debt stays closer to $146B or $1629B before net debt modeling.
If you’re using this topic for a paper or case study, a structured SWOT Analysis, PESTLE Analysis, or Business Model Canvas can help you organize the research into clear arguments. Mission Statement, Vision, & Core Values (2026) of Bunge Limited (BG) can also help connect balance-sheet strength with strategy and capital allocation.
Capital Efficiency
Is Bunge Global SA funding growth efficiently?
Mixed. Bunge Global SA looks capable of funding part of its growth from internal cash, but the combination of $15B–$17B in projected capital spending, a large share repurchase plan, and Viterra-related dilution and leverage makes the full funding picture less clean. For strategy context, see Mission Statement, Vision, & Core Values (2026) of Bunge Limited (BG).
Return measures need to be read alongside leverage, asset intensity, capital expenditure, working capital swings, and any outside funding. A company can post strong returns on paper and still strain cash if it is building capacity, buying assets, or carrying more debt. That is why capital efficiency is as much about funding discipline as it is about profit rates.
| Capital Measure | Latest Evidence | Quality Test | Investor Meaning |
|---|---|---|---|
| ROIC | Management signaled a sustainable ROIC above 100% at the March 10, 2026 planning update. | That is a strong signal if margins stay firm and capital stays disciplined; the test is whether new projects earn similar returns. | Invested capital appears able to create operating value if the return profile holds through biofuels and downstream expansion. |
| ROE and ROA | Specific ROE and ROA figures were not supplied; Viterra consideration included 656M Bunge shares and approximately $9000M in cash. | Leverage can lift ROE, while asset-heavy processing can pressure ROA, so neither metric should be read as automatic strength. | Shareholder returns may look better if leverage supports earnings, but asset efficiency still matters for quality. |
| Maintenance and Growth Investment | Projected capital expenditures of $15B–$17B, with growth in biofuels, operational maintenance, downstream renewable fuels, and plant-based proteins. | The mix suggests both upkeep and expansion are capital intensive, with growth likely requiring sustained reinvestment. | Capital needs appear high enough that growth is not cheap, even if the long-term earnings target improves scale. |
| Internal Funding Capacity | $30B share repurchase program, target to return at least 500% of discretionary cash flow to shareholders, and a quarterly cash dividend of $072 per share. | Internal cash may fund some reinvestment, but buybacks, dividends, and acquisition-related dilution mean outside funding pressure still matters. | Funding looks partly internal, but leverage, dilution, and cash retention will shape flexibility and shareholder returns. |
Are Bunge Global SA’s returns on capital sustainable?
Mostly yes, if management keeps margins, asset use, and project discipline near the planned level. The strongest durability source is the stated sustainable ROIC above 100%; the main weakening risk is heavy reinvestment combined with acquisition-related leverage and dilution.
- Operating Source: Sustainable ROIC above 100% and the higher-value mix from biofuels and downstream capabilities.
- Funding Requirement: The largest verified need is projected capital expenditures of $15B–$17B.
- Durability Test: Returns weaken if the long-term $1500 per share earnings goal slips while leverage, dilution, or working capital needs rise.
Balance Sheet Risk
What warning signs could weaken Bunge Global SA’s resilience?
Resilience is Mixed. The main buffer is the company’s integrated operations and alternative shipping routes, plus $700M in synergy targets by year-end 2025. The most important verified warning sign is refinancing exposure after the $12B senior notes issuance and $146B in total debt as of March 31, 2026.
Bunge Global SA can absorb some stress if cash conversion stays solid, but resilience gets weaker if margins fall, working capital stays heavy, or funding costs rise. Investors should watch whether liquidity from traded inventories and operating cash flow is enough to cover debt service and ongoing investment without strain.
| Pressure | Financial Effect | Existing Protection | Warning Signal |
|---|---|---|---|
| Revenue or Margin Pressure | Lower margins would reduce operating leverage, earnings, cash flow, and debt capacity. | Integrated operations and $700M in synergy targets by year-end 2025 can help offset some pressure. | Watch for weaker revenue, margin compression, or declining cash flow. |
| Working-Capital or Investment Pressure | Inventory and marketable inventories can support sales, but they also absorb cash and require funding discipline. | $1543B of Inventory and $134B of Readily marketable inventories provide liquidity support if conversion stays efficient. | Monitor slower operating cash flow, rising inventory, or heavier cash tied up in operations. |
| Interest or Refinancing Pressure | $12B of senior notes and $146B in total debt can raise interest expense, reduce free cash flow, and limit flexibility. | Alternative shipping routes and operating scale help, but debt maturity management matters most. | Watch interest expense, refinancing terms, and any tighter liquidity signals. |
Which financial warning signs should investors monitor at Bunge Global SA?
The top signals are refinancing pressure, cash conversion, and foreign exchange losses. The $12B senior notes and $146B debt are confirmed balance-sheet risks; weaker operating cash flow or more currency losses would show future strain.
Refinancing and interest cost pressure
The $12B senior notes and $146B total debt increase exposure to higher interest expense and refinancing risk. The offset is scale and operating cash generation, so the next metric to watch is interest expense and debt maturity planning.
Inventory funding intensity
$1543B of Inventory and $134B of Readily marketable inventories can support liquidity, but they also tie up cash. The key check is whether operating cash flow keeps pace with inventory levels and working-capital needs.
FX and shipping-route volatility
A $940M net foreign exchange loss in Q1 2026 shows currency volatility can hit results fast. Middle East shipping risk tied to the Strait of Hormuz adds disruption risk, even with alternative routes, so investors should monitor FX results and trade-route stability.
Mixed financial health
What does Bunge Global SA’s financial health mean for investors?
Bunge Global SA’s scorecard is Mixed. The strongest factor is scale, while the weakest is leverage. The most important condition for the investment case is whether earnings and cash flow can hold up while debt stays manageable.
| Financial Factor | Rating | Evidence and Investor Meaning |
|---|---|---|
| Revenue and Earnings Quality | Mixed | FY2025 Net Sales rose 755%, but FY2025 Adjusted EPS fell to $757 from $919. Growth is visible, but per-share earnings quality looks less durable. |
| Profitability and Cash | Mixed | Q1 2026 Operating Income was $111B, but Operating Cash Flow Growth was -14046% and Free Cash Flow Growth was -20976%. Profit exists, but cash conversion is weak. |
| Balance Sheet and Liquidity | Mixed | Total Current Assets were $2709B and readily marketable inventories were $134B, but total debt was $146B. Liquidity helps, yet leverage remains a real constraint. |
| Capital Efficiency | Mixed | Management targets ROIC above 100% while capex remains $15B–$17B. Returns could improve, but reinvestment needs still demand steady funding. |
| Financial Resilience | Mixed | Scale and inventories support resilience, but FX loss and integration risk remain. That leaves less room for error if operating conditions weaken. |
- What Supports the Thesis: Large scale, sizable current assets, and readily marketable inventories give Bunge Global SA operating flexibility.
- What Challenges the Thesis: Total debt, weak cash conversion, and integration risk create the main uncertainty for investors.
- What to Monitor: Adjusted EPS, Free Cash Flow Growth, total debt.
For forecasts, scenarios, and valuation, the key question is whether earnings quality and cash generation improve enough to support the balance sheet.
FAQ
What Do Investors Ask About 's Financial Health?
Investors most often ask about the company's revenue quality, profitability, cash generation, debt, liquidity, capital efficiency, and ability to withstand financial pressure.
What does Bunge debt mean for liquidity?
Bunge’s debt increases the need for disciplined cash management after Viterra Total debt was $146B as of March 31, 2026, while Cash And Short Term Investments were $170B and Total Current Assets were $2709B at 2026-03-31
Why did Bunge EPS decline after Viterra?
FY2025 Net Sales grew 755%, but Adjusted EPS fell to $757 from $919 and GAAP Diluted EPS fell to $493 from $799 The key point is that larger scale did not fully translate into per-share earnings during the integration year
How much capex does Bunge expect?
Bunge projected annual capital expenditures of $15B–$17B for 2025–2026 The spending focus is growth projects in biofuels and operational maintenance, so investors should test whether operating cash flow can fund reinvestment and shareholder returns
Is Bunge ROIC improving enough for investors?
The supplied data gives a management target, not an actual ROIC result Management set a sustainable ROIC goal above 100% and a mid-cycle earnings baseline of approximately $1300 per share, so investors should monitor delivery against those targets
What cash flow metric matters most now?
Free Cash Flow Growth matters because Bunge is larger, more leveraged, and still reinvesting FMP shows Free Cash Flow Growth of -20976% for 2026-03-31, so analysts should review operating cash flow, capex, and working capital before judging cash durability